Each year, about 100,000 women undergo surgical procedures to remove uterine fibroids in U.S. health care facilities. It is estimated that one in 350 removal procedures using power morcellators results in the spread of undetected cancer throughout the body. A power morcellator is a device that uses a fast-spinning blade... Read more »

More than 60,000 women of varying ages have sought legal recourse for serious injuries and financial hardships attributed to transvaginal mesh devices manufactured to help treat urinary incontinence and pelvic organ prolapse. Plaintiffs allege that defendants distributed defective products without sufficient trials or warnings about bladder sling problems such as... Read more »

In a bellwether case tried in Miami federal court, jurors found mesh manufacturer Boston Scientific liable for distributing defective devices, and ordered the company to pay more than $26 million. As reported by Reuters, the transvaginal mesh lawsuit award was rendered following a tense eight day trial. Four plaintiffs who... Read more »

Last week, in response to calls for a laparoscopic power morcellator recall, the U.S. Food and Drug Administration (FDA) announced that the surgical devices would be given a new boxed warning on the labels. The boxed warning is the strictest warning that the FDA requires short of pulling a device from... Read more »

Dr. Hooman Noorchashm, a cardiothoracic surgeon at Brigham and Women’s Hospital, and his wife, Dr. Amy Reed, have launched a crusade aimed at convincing the FDA that a complete and total ban on power morcellators is necessary to save lives. Like many other women who have filed a cancer-related power... Read more »

The first Pinnacle hip implant trial has ended in favor of the defendants. The jury in the case determined that the plaintiff’s injuries were not caused by a device defect and that manufacturers DePuy and Johnson & Johnson provided proper warning about potential risks associated with their product. The lawsuit... Read more »

Leading orthopedics manufacturer, Stryker Corp. recalled its Rejuvenate and ABG II hip replacement implants in July 2012 after discovering the devices could cause adverse tissue reactions and other incapacitating health problems. The company announced that it has earmarked some $1.4 billion for Stryker Rejuvenate settlements to cover litigation and medical... Read more »

As thousands of lawsuits mount across the country over Mirena IUD risks, a new study by the American College of Obstetrics & Gynecology focuses on a woman’s age and number of pregnancies as possible factors in IUD expulsion. The three-year study compared these risk factors in women implanted with hormonal... Read more »

Attorneys for both sides continue to engage in mediation to reach Stryker Rejuvenate hip settlements, so the thousands of pending cases don’t have to be tried individually in courts across the nation. More than 4,000 product liability cases are currently pending against the medical device manufacturer in state and federal... Read more »

After a jury ordered transvaginal mesh manufacturer C.R. Bard to pay a substantial amount to a plaintiff last year, the company began exploring settlement agreements. Now, the company has announced that it has reached an agreement with more than 500 plaintiffs, which is the first large scale effort to settle... Read more »